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From antiseptics to antibiotics – and back?
Von der Antiseptik zur Antibiotik – und zurück?
Abstract
There is no straight line to trace the trajectory of antiseptics; rather,
this has been manifested more as a fluctuating line, a backwards and
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forwards movement, seen in the wake of major discoveries but of co-
1 Clinical Department for Hos-
pital Hygiene, Clinical Insti-
lossal mistakes too. While today no one would allow their prophylactic
policies to be guided by miasma or contagia, there continues to be tute for Hygiene and Micro-
some uncertainly about how to manage anti-infectives effectively even
today.
biologyoftheMedicalUniver-
sityofVienna,GeneralHospi-
tal of Vienna, Austria When in 1941 the first human being was successfully treated with
penicillin, interest in antiseptics gradually waned. From that time on-
wards, everything was treated with antibiotics, unleashing a race for
the discovery of novel antibiotics, as witnessed decades earlier in the
case of antiseptics. The significance of antiseptics declined to such an
extentthatamongphysicianstheywereassociatedmerelywithcleaning
agentsorsanitarydisinfection.Today,atthebeginningofthe21
stcentury
we know that the euphoria generated by antibiotics was just another
station along the pathway of discoveries. Bacterial infections and new,
hitherto unknown infectious diseases continue to play a major role.
Severalviralinfectionscontinuetoberefractorytosuccessfultreatment
and bacterial antibiotic resistance has become a problem worldwide.
The most effective countermeasures no longer entail only the develop-
ment of new antibiotics but above all responsible management of anti-
biotics and strict observance of infection control measures in the hos-
pital setting. Set against that background, interest in antiseptics has
been rekindled. In that spirit we can look eagerly forward over the
coming years to further developments in antisepsis.
Zusammenfassung
Es ist keine gerade Linie, die die Entwicklung der Antiseptik kennzeich-
net, sondern wohl eher ein Auf und Ab, ein Hin und Her, eine Folge
großer Erkenntnisse und ebenso großer Irrtümer. Niemand würde
heute mehr sein Handeln an “Miasmen“ oder „Contagien“ ausrichten,
wenn es um die Infektionsprophylaxe geht, wirklich sicher ist man sich
aber auch heute noch nicht immer im Verständnis und Umgang mit
Antiinfektiva.
Als 1941 der erste Mensch erfolgreich mit Penicillin behandelt wurde,
nahm das Interesse an Antiseptika sukzessive ab. Fortan wurde alles
mitAntibiotikabehandeltundähnlichwieJahrzehntezuvorbeiAntisep-
tika, setzte ein Rennen um die Entdeckung von neuen Antibiotika ein.
Antiseptika rutschen so sehr in ihrer Bedeutung ab, dass sie unter
Medizinern lediglich mit Putzmittel oder Sanitärdesinfektion assoziiert
wurden. Heute, zu Beginn des 21. Jhd. wissen wir, dass die Antibiotika-
Euphorie auch nur eine Zwischenstufe in der Erkenntnishirarchie war.
Bakterielle Infektionen und neue, bisher unbekannte Infektionskrank-
heiten spielen eine unverändert große Rolle. Viele Virusinfektionen
entziehen sich nach wie vor einer erfolgreichen Behandlung und die
bakterielle Antibiotikaresistenz hat sich zu einem weltweiten Problem
entwickelt.ZudenwirksamenGegenmaßnahmengehörenheutewieder
nicht nur die Entwicklung neuer Antibiotika, sondern vor allem das
verantwortungsvolle Umgehen damit und die strikte Beachtung kran-
1/5 GMS Krankenhaushygiene Interdisziplinär 2007, Vol. 2(1), ISSN 1863-5245
Original Contribution OPEN ACCESSkenhaushygienischer Maßnahmen. Das Interesse an Antiseptika ist
dafür wieder neu belebt. In diesem Sinne können wir in den nächsten
Jahren mit Spannung auf die Weiterentwicklung der Antiseptik blicken.
Text
ProfessorJosefNowak,chairmanofthenewlyintroduced
professorshipforinfectioncontrolinViennain1881wrote
the following sentence in this publication, the very first
Austrian Textbook for Infection Control (Lehrbuch der
Hygiene): “One of the most important aims of infection
control research is to ascertain the causes of infectious
diseases and to identify means and ways to prevent or
attenuate them.”
His summary of the prevailing perceptions of the causes
of infectious diseases cast the deep-seated and contro-
versially discussed views held at that time into sharp re-
lief:“Sincefromthedivergentopinionsexpressedabove,
itmustbeconcludedthattodateithasnotbeenpossible
toclassifythecausesofdiseasesandinfectiousdiseases
in the light of the latest research, we have no choice at
present but to continue to content ourselves with the
designations miasma and contagium.”
In particular, perceptions of the causes of infectious dis-
eases had fundamental implications for the ways and
means used to combat such infectious diseases. During
the Middle Ages people were of the opinion that the
quality of well water was one of the chief determinants
of whether or not epidemics were going to take place.
Hence at that time it was only logical to conclude that a
wellthathadpreviouslysuppliedsafewatercouldbecome
toxic only if it had first been poisoned. And of course all
too soon scapegoats were pinpointed, against whom the
common anger could be unleashed. But once the anger
had been appeased, the epidemics continued.
Later, it was believed that dangerous vapors in the air
were the cause of epidemics and infirmity. But the publi-
cations by Louis Pasteur marked the first steps on the
scientific and systematic pathways that would eventually
provedecisiveforthemajorbreakthroughsinthepreven-
tion and treatment of infectious diseases.
After reading Pasteur’s germ theory in 1865, Sir Joseph
Listerconcludedthatifinfectionswerecausedbymicroor-
ganisms then the most effective way to prevent postsur-
gical wound infections was to kill these microorganisms
before they could reach the open wound. In pursuit of
this,ListerdidnotoptforheatorfiltrationasPasteurhad
done; rather, he decided to use a chemical antiseptic in
the form of carbolic acid which had already been used
elsewherefordisinfection.Inhisbook“AntisepticPrinciple
of the Practice of Surgery”, published in 1867, Lister de-
scribed the use of carbolic acid as follows “The material
which I have employed is carbolic or phenic acid, a
volatile organic compound, which appears to exercise a
peculiardestructiveinfluenceuponlowformsoflife,and
hence is the most powerful antiseptic with which we are
at present acquainted.”
Following this, Lister incorporated the strict implementa-
tion of antisepsis into hospital routine activities. Such
measuresincluded,inparticular,antiseptichandwashing
with carbolic solutions, instrument disinfection and the
use of wound dressings impregnated in carbolic acid, al-
beit they also included the vaporization of carbolic acid
into the ambient air. Despite the fact that the latter pro-
cedures posedrisksnot only tothe person implementing
them but also to the patients, they soon became wide-
spread practice worldwide thanks to their enormous
success,whileensuringthatLister’steachingsofantisep-
tic surgery became renowned in Europe and the USA.
Onapurelyspeculativenote,onewonderstowhatextent
Lister based his method solely on the contagium theory
or to what degree belief in miasmatic causes continued
to play a role. While disinfection of hands, instruments
and wounds continue to be important right up to the
present day, albeit using other substances rather than
carbolicacid,vaporizationofcarbolicacidisprobablythe
mostineffective,butmosthazardous,methodofinfection
prevention. Although Lister puts forward arguments
claiming that this measure is in complete harmony with
his initial perceptions of preventing the introduction of
low life forms into the wound already at the outset, in
other publications he admits that the “bad air” in itself
can cause disease.
But Lister’s association with preventive antisepsis re-
mains undisputed up to the present day. However, this
impression reflects only part of the total potential appli-
cationspectrumofantiseptics,bearinginmindthatLister,
himself, had successfully used antiseptics for treatment
of existing infections.
Once antiseptics began to become established as an
important factor despite scientific disputes, it was not
surprisingthatintheaftermathoftheirdiscoveryahectic
search was launched for more antiseptics. Indeed, some
of the proposals and formulations put forward were so
highly adventurous that Otto Nägeli could not resist issu-
ing the following warning: “For some people the fact that
something is a poison is justification enough to justify its
use as a disinfectant. How it works and the amount of it
needed for a particular effect is something to which no
one has devoted any thought. There are disinfectant for-
mulations that give the experienced researcher the im-
pression, such as for example the opinion of a semi-
educated person, he could kill himself with a bitter al-
mond since it contains cyanic acid”. This quotation from
Nägel can be extrapolated without any significant modi-
fication to a whole range of what are known today as
novel antiinfective products.
Arecurringprotagonistintheseendeavorsissilver.Since
earlytimessilver-containingcompoundshavebeenused
in medicine, with silver-based formulations enjoying a
sharp upswing in popularity in the late 19th century.
Around 1940 well over 4 dozen different silver prepara-
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or topical preparations for treatment of all infectious
diseasesknown.Thesehadimpressivenames,e.g.Albar-
gin, Argonin, Argyn, Argyrol, Largin, Lunosol, Novargan,
Proganol, Electrargol or Silvol. Some of these products
differed considerably from each other; some consisted
of colloidal silver, others of colloidal silver salt com-
pounds,whileotherswerenotusedatallincolloidalform
but rather in solid form. The silver content ranged from
minimal concentrations up to a 30% silver content of the
entire weight. Accordingly, there were also marked differ-
ences in their effectiveness and side effects depending
on the manufacturing conditions, galenics, preparation,
age and quality of ingredients. However, none of these
products were as effective as silver nitrate or silver acet-
ate, which continued to be used successfully up till the
recent past in several countries in the form of Crede’s
prophylaxis for prevention of neonatal ophthalmia. In the
meantime, other substances are being used today for
this indication too, due to the cytotoxic side effects well
knowntomidwivesaschemicalconjunctivitis.Noteworthy
hereisthetrajectoryviatheinitialuseofantibioticsback
to antiseptics again for this indication in the form of
1.25% povidone-iodine.
It is most fortuitous that the antiseptic principle came on
the scene precisely at a time when the first inroads were
being made into bacteriology. Up till then, virtually none
oftheimportantmicrobeswasknown.Itwasonlyasfrom
the mid1870s when more and more bacteria were being
discovered that it was possible to conduct experiments
to investigate the effects exerted by certain substances
on these bacteria. Soon it was noted that a range of
substances exerted an inhibitory, or even in some cases
alethal,effectondifferentmicroorganisms.Theseagents
proved effective only in certain concentrations and only
whentheywereinveryclosecontactwithmicroorganisms.
Likewise, soon it could not be overlooked that regardless
ofhowsuccessfulasubstancehadprovedtobeincertain
cases, it could not be assumed that it would generate a
microbicidal effect in other cases too. For example,
Buchholz in Vienna published the results of experiments
that revealed that the following substances in certain
concentrations were able to prevent bacterial growth in
a nutrient liquid: sublimate in a dilution of 1:20000,
thymol 1:2000, benzoic acid, sodium hydroxide solution
1:2000, creosote 1:1000, benzoic acid 1:1,000, salicyl
acid 1:666, carbolic acid 1:200, quinine 1:200, alcohol
1:50,chlorine1:25000,sulfurousacid1:666,andvapors
of nitric acid 1:666.
According to Nowak, of the aforementioned “disinfec-
tants” only very few could be used in practice due to tox-
icityor high cost;these were carbolicacid, sulfurousacid
and chlorine.
The investigations carried out by Robert Koch at the Im-
perial Health Office played a trailblazing role. In addition
to other substances, Koch also investigated the effects
mediated by carbolic acid and was able to demonstrate
that in its conventional 2% dilution it had no effect on
anthrax spores. Only a 4%, or better a 5%, carbolic solu-
tion reliably killed the spores. But the spores had to be
exposed to the carbolic acid for a long time to achieve
these results. If the items to be disinfected were merely
sprinkled, sprayed, washed or wetted in another way, all
viable bacteria were not killed even after repeating this
test on ten occasions, making Koch realize that any form
of disinfection conducted in this manner would prove
unreliable. In other experiments he was able to demon-
strate that carbolic acid dissolved in oil or alcohol did not
have the slightest disinfectant effect. Using the same
method as for carbolic acid, further experiments were
conducted with sulfurous acid and with zinc chlorine,
which among other things had been recommended as
one of the most effective disinfectants in the 1870s. The
outcome of all these tests was none of the disinfectants
in whose use much confidence had been hitherto vested
was able to meet the requirements now addressed by
bacteriology to such agents. Koch stressed that it was
not enough to destroy the living forms of bacteria; rather,
what was important was to render unviable the spores
which were much more resistant. He then turned his at-
tention to other methods with the hope of discovering
more reliable forms of disinfection. What a fateful inter-
pretation by one of the real key players of bacteriology!
Apartfromhissubsequentmisinterpretationofbeingable
to use tuberculin as a remedy against tuberculosis, Koch
drew his second incorrect conclusion in the demands he
addressed to antisepsis. While by placing the emphasis
on spores, he made a significant contribution to spurring
on the development of sterilization processes, without
which asepsis would not at all have been possible, ongo-
ing trends in antisepsis damaged Koch’s new line of re-
search at least to a certain extent and for some time.
Oddly enough present-day research into antisepsis con-
sistsof,amongotherthings,conductingsimplemicrobio-
logicaltestsinasystematicmanner,whichaheavyweight
like Koch would no doubt have carried out himself were
hetoplacethemainemphasisofhisactivitiesonprevent-
iveandtherapeuticaspectsofantisepsis,whileexcluding
the effects exerted on spores. Apart from the “spores’
gap“, a shortcoming that can be imputed to many if not
all antiseptics, already in the early 20th century there
wasaneedfor“antiseptics“thatcouldbealsointroduced
into the bloodstream so as to inactivate pathogens in
bodyregionsthatcouldnotbeaccessedwiththeavailable
substances.
Koch offered some insights into what was possible in
1906 when during his Africa expedition he detected the
favorable effects exerted by atoxyl (natrium-4-
aminophenylhydrogenarsonate) on sleeping sickness.
However, Koch did not pursue this line of research since
non-toxic doses exerted only a slight effect.
Nonetheless,thisreferencehelpedtodrawPaulEhrlich’s
attention to atoxyl, who, however, recognized that
pentavalent arsenic compounds exerted only a weak in
vitro effect against microbes, thus concluding that it was
only within the human organism that the substance was
converted into the actually active substance. Hence Ehr-
lich concentrated his attention on the quest for a “magic
3/5 GMS Krankenhaushygiene Interdisziplinär 2007, Vol. 2(1), ISSN 1863-5245
Assadian: From antiseptics to antibiotics – and back?pill”, on trivalent arsenic compounds. In 1909 salvarsan
(preparation 606, dioxy-diamino-arsenobenzol-dihydro-
chloride) was developed by Ehrlich and Sahachiro Hata
and was available on the market already as from 1910.
However, since the substance was so toxic that it could
be injected intravenously only at most every 7 days while
taking utmost precautions, the quest continued for
products with better tolerability profiles.
This vision lent momentum to the working activities of
the Scottish physician Alexander Flemming carried out
in London during the 1920s. To begin with, Flemming
investigated human tear fluid and discovered to his
amazement that this was capable of killing bacteria.
Flemming called the ingredients responsible for this
“lysozyme“. But his expectations were soon to be under-
mined by further investigations. It soon emerged that
while lysozyme was able to destroy bacteria, it could kill
only those that in principle were harmless to humans.
Noneofthebacteriaknownatthattimetobepathogenic
were even remotely affected by lysozyme, not to speak
of being killed by it.
Thanks to the now most famous bacteriological error,
contaminationofastaphylococciculturewithPenicillium
chrysogenum, Flemming made an amazing discovery in
1928. Penicillin was (re-) discovered. Since already back
in1897ErnestDuchesneworkingattheEcoleduService
deSantéMilitairedeLyondefendedtheviewsexpressed
in his doctorial thesis “Contribution à l’étude de la con-
currencevitalechezlesmicro-organismes:antagonisme
entre les moisissures et les microbes“ (A contribution to
thestudyofthevitalcompetitionamongmicroorganisms:
antagonism between moulds and microbes), by giving a
detailedaccountofthebactericidalactivityofPenicillium
glaucum. His work elicited little attention and was soon
forgotten again.
YearsweretogobybeforeHowardFloreyandErnstChain
succeeded in producing penicillin as a pure substance.
When in 1941 the first human being was successfully
treated (with an antibiotic), interest in antiseptics gradu-
ally waned. From that time onwards, everything was
treated with antibiotics, unleashing a race for the discov-
ery of novel antibiotics, as witnessed decades earlier in
the case of antiseptics.
Thesignificanceofantisepticsdeclinedtosuchanextent
that among physicians they were associated merely with
cleaning agents or sanitary disinfection. For many dec-
ades, courage, a robust character, farsightedness and
vision were needed to take on the topic of antiseptics.
Accordingly, even today compared with antibiotics there
isapaucityofliteratureexplainingtheprincipleofaction,
applicationfieldsandpotentialinteractionsofantiseptics
with other substances.
Aftermanyyearsofeuphoria,SirMacfarlaneBurnetwrote
towards the end of the 1960s that infectious diseases
would be largely eradicated by the close of the 20th
century. Today, at the beginning of the 21st century we
know that this optimistic view has proved to be incorrect.
Bacterialinfectionsandnew,hithertounknowninfectious
diseasescontinuetoplayamajorrole.Severalviralinfec-
tions continue to be refractory to successful treatment
andbacterialantibioticresistancehasbecomeaproblem
worldwide. Furthermore, the competition between bac-
teria and antibiotics now appears to be slanted in favor
of the bacteria on reaching an economic plateau. The
most effective countermeasures no longer entail the de-
velopment of new antibiotics but above all responsible
managementofantibioticsandstrictobservanceofinfec-
tioncontrolmeasuresinthehospitalsetting.DennisMaki
summed up the situation in a succinct manner: “The de-
velopmentofnewantibioticswithouthavingmechanisms
to endure their appropriate use is much like supplying
your alcoholic patients with a finer brandy!”
Even though antiseptics were temporarily overshadowed
by antibiotics, the broad spectrum and non-critical use
ofantisepticshelpedtodrawattentiontonewandserious
problems.Sincewecannowclearlyforeseethelimitations
of antibiotics, it is not surprising that interest in antisep-
tics is being rekindled. Deployed for prophylactic or
therapeuticpurposes,antisepsiscaninactivateorimpede
thegrowthofmicroorganisms.Potentialapplicationsites
coincide with the portals of entry of microbes or of mani-
fest infection foci on the body surface (skin, mucosa,
wounds),inbodycavities(punctures,catheters)andwith
surgicallyexposedoropenedareas.Tailoredtothediffer-
entapplicationsites,skin,mucosalandwoundantiseptics
are available.
OnehundredandthirtyyearslaterwereturntoProfessor
JosefNowak:“Oneofthemostimportantaimsofinfection
control research is to ascertain the causes of infectious
diseases and to identify means and ways to prevent or
attenuatethem.”Inthisspiritwecanlookeagerlyforward
over the coming years to further developments in anti-
sepsis.
Of imminent importance and as the basis for further
concrete research and development, clarification of the
definitions used hitherto is needed first of all. Today, we
findourselvesinasituationwhereitisbecomingincreas-
ingly more difficult to clearly and concisely distinguish
betweentermssuchasantibiotic,antiseptic,chemothera-
peutic,biocide,disinfectantorantiinfective.Development
of new substances, new fields of application and the
discovery of new pathogens cause obfuscation of the
terms used hitherto. To avoid confusing ourselves, our
students and patients in the future our nomenclature
must be brought into line with new developments while
reaching a broad consensus.
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